STOCK TITAN

[8-K] CME GROUP INC. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

CME Group Inc. furnished an 8-K announcing quarterly results. The company reported that a press release dated October 22, 2025, covering financial results for the quarter ended September 30, 2025, was furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition).

The press release includes non-GAAP measures—revenues, expenses, operating income, net income, and earnings per share—with reconciliations to the most comparable GAAP metrics pursuant to Regulation G. The Item 2.02 information, including the exhibit, is furnished and not deemed filed under Section 18 of the Exchange Act.

CME Group Inc. ha fornito un 8-K annunciando i risultati trimestrali. L'azienda ha riferito che un comunicato stampa datato 22 ottobre 2025, relativo ai risultati finanziari del trimestre chiuso al 30 settembre 2025, è stato fornito come Allegato 99.1 ai sensi della Voce 2.02 (Risultati operativi e stato finanziario).

Il comunicato stampa include misure non-GAAP—ricavi, spese, reddito operativo, reddito netto e utile per azione—con rettifiche rispetto alle metriche GAAP più comparabili, ai sensi del Regolamento G. Le informazioni dell'Articolo 2.02, inclusi l'allegato, sono fornite e non ritenute depositate ai sensi della Sezione 18 dello Securities Exchange Act.

CME Group Inc. presentó un 8-K anunciando resultados trimestrales. La compañía informó que un comunicado de prensa con fecha del 22 de octubre de 2025, que cubre los resultados financieros del trimestre terminado el 30 de septiembre de 2025, se presentó como Anexo 99.1 conforme al Item 2.02 (Resultados de operaciones y estado financiero).

El comunicado incluye medidas no GAAP—ingresos, gastos, resultado operativo, ingreso neto y utilidad por acción—con conciliaciones a las métricas GAAP más comparables conforme al Reglamento G. La información del Item 2.02, incluido el anexo, se proporciona y no se considera presentada conforme a la Sección 18 de la Ley de Intercambio.

CME Group Inc.은 분기 실적을 공시하는 8-K를 제출했습니다. 회사는 2025년 10월 22일자 보도자료가 2025년 9월 30일로 끝난 분기의 재무실적을 다루며 항목 2.02(영업실적 및 재무상태)에 따라 부속문서 99.1로 제출되었다고 보고했습니다.

보도자료에는 Regulation G에 따라 가장 비교 가능한 GAAP 지표에 대한 조정이 있는 비-GAAP 지표—매출, 비용, 영업이익, 순이익 및 주당순이익—가 포함되어 있습니다. 항목 2.02의 정보(부속문서 포함)는 Exchange Act의 섹션 18에 따라 제출되며 제출로 간주되지 않습니다.

CME Group Inc. a fourni un 8-K annonçant les résultats trimestriels. L'entreprise a indiqué qu'un communiqué de presse daté du 22 octobre 2025, couvrant les résultats financiers du trimestre clos le 30 septembre 2025, a été fourni en tant qu'Annexe 99.1 conformément à l'Article 2.02 (Résultats des opérations et situation financière).

Le communiqué inclut des mesures non GAAP—revenus, dépenses, résultat opérationnel, résultat net et bénéfice par action—with des rapprochements vers les métriques GAAP les plus comparables, en vertu du Règlement G. Les informations de l'Article 2.02, y compris l'annexe, sont fournies et non réputées déposées en vertu de la Section 18 de la Exchange Act.

Die CME Group Inc. hat eine 8-K vorgelegt, in der die Quartalsergebnisse angekündigt werden. Das Unternehmen teilte mit, dass eine am 22. Oktober 2025 datierte Pressemitteilung, die die Finanzergebnisse für das am 30. September 2025 endende Quartal abdeckt, als Anhang 99.1 gemäß Punkt 2.02 (Ergebnisse der Geschäftstätigkeit und Finanzlage) vorgelegt wurde.

Die Pressemitteilung enthält Non-GAAP-Maßnahmen—Umsätze, Aufwendungen, operatives Ergebnis, Nettogewinn und Gewinn je Aktie—mit Abgleichungen zu den vergleichbarsten GAAP-Metriken gemäß Regulation G. Die Informationen des Punktes 2.02, einschließlich des Anhangs, werden vorgelegt und gelten nicht als eingereicht gemäß Abschnitt 18 des Exchange Act.

قامت CME Group Inc. بتقديم نموذج 8-K يعلن عن النتائج الفصلية. أفادت الشركة بأن بياناً صحفياً مؤرخاً 22 أكتوبر 2025، يغطي النتائج المالية للربع المنتهي في 30 سبتمبر 2025، قد تم تقديمه كـ الملحق 99.1 وفقاً للبند 2.02 (نتائج العمليات والوضع المالي).

يشمل البيان الصحفي مقاييس غير GAAP—الإيرادات، النفقات، الدخل التشغيلي، الدخل الصافي، وربح السهم—مع مقارنات مع أكثر مقاييس GAAP قابلية للمقاربة وفقاً للوائح Regulation G. معلومات البند 2.02، بما في ذلك الملحق، مقدمة وليست مُعتبرة كملف بموجب القسم 18 من قانون التبادل.

CME Group Inc. 已提交一份8-K公告季度业绩。 公司报告称,一份日期为2025年10月22日的新闻稿,涵盖截至2025年9月30日的季度财务业绩,已按2.02条款(经营成果及财务状况)作为附件99.1提交。

新闻稿包含非GAAP指标——收入、费用、经营利润、净利润和每股收益——并按Regulation G就最可比的GAAP指标进行了对账。2.02条款的信息(包括附件)已被呈送,且不被视为根据交易法第18条备案。

Positive
  • None.
Negative
  • None.

CME Group Inc. ha fornito un 8-K annunciando i risultati trimestrali. L'azienda ha riferito che un comunicato stampa datato 22 ottobre 2025, relativo ai risultati finanziari del trimestre chiuso al 30 settembre 2025, è stato fornito come Allegato 99.1 ai sensi della Voce 2.02 (Risultati operativi e stato finanziario).

Il comunicato stampa include misure non-GAAP—ricavi, spese, reddito operativo, reddito netto e utile per azione—con rettifiche rispetto alle metriche GAAP più comparabili, ai sensi del Regolamento G. Le informazioni dell'Articolo 2.02, inclusi l'allegato, sono fornite e non ritenute depositate ai sensi della Sezione 18 dello Securities Exchange Act.

CME Group Inc. presentó un 8-K anunciando resultados trimestrales. La compañía informó que un comunicado de prensa con fecha del 22 de octubre de 2025, que cubre los resultados financieros del trimestre terminado el 30 de septiembre de 2025, se presentó como Anexo 99.1 conforme al Item 2.02 (Resultados de operaciones y estado financiero).

El comunicado incluye medidas no GAAP—ingresos, gastos, resultado operativo, ingreso neto y utilidad por acción—con conciliaciones a las métricas GAAP más comparables conforme al Reglamento G. La información del Item 2.02, incluido el anexo, se proporciona y no se considera presentada conforme a la Sección 18 de la Ley de Intercambio.

CME Group Inc.은 분기 실적을 공시하는 8-K를 제출했습니다. 회사는 2025년 10월 22일자 보도자료가 2025년 9월 30일로 끝난 분기의 재무실적을 다루며 항목 2.02(영업실적 및 재무상태)에 따라 부속문서 99.1로 제출되었다고 보고했습니다.

보도자료에는 Regulation G에 따라 가장 비교 가능한 GAAP 지표에 대한 조정이 있는 비-GAAP 지표—매출, 비용, 영업이익, 순이익 및 주당순이익—가 포함되어 있습니다. 항목 2.02의 정보(부속문서 포함)는 Exchange Act의 섹션 18에 따라 제출되며 제출로 간주되지 않습니다.

CME Group Inc. a fourni un 8-K annonçant les résultats trimestriels. L'entreprise a indiqué qu'un communiqué de presse daté du 22 octobre 2025, couvrant les résultats financiers du trimestre clos le 30 septembre 2025, a été fourni en tant qu'Annexe 99.1 conformément à l'Article 2.02 (Résultats des opérations et situation financière).

Le communiqué inclut des mesures non GAAP—revenus, dépenses, résultat opérationnel, résultat net et bénéfice par action—with des rapprochements vers les métriques GAAP les plus comparables, en vertu du Règlement G. Les informations de l'Article 2.02, y compris l'annexe, sont fournies et non réputées déposées en vertu de la Section 18 de la Exchange Act.

Die CME Group Inc. hat eine 8-K vorgelegt, in der die Quartalsergebnisse angekündigt werden. Das Unternehmen teilte mit, dass eine am 22. Oktober 2025 datierte Pressemitteilung, die die Finanzergebnisse für das am 30. September 2025 endende Quartal abdeckt, als Anhang 99.1 gemäß Punkt 2.02 (Ergebnisse der Geschäftstätigkeit und Finanzlage) vorgelegt wurde.

Die Pressemitteilung enthält Non-GAAP-Maßnahmen—Umsätze, Aufwendungen, operatives Ergebnis, Nettogewinn und Gewinn je Aktie—mit Abgleichungen zu den vergleichbarsten GAAP-Metriken gemäß Regulation G. Die Informationen des Punktes 2.02, einschließlich des Anhangs, werden vorgelegt und gelten nicht als eingereicht gemäß Abschnitt 18 des Exchange Act.

false000115637500011563752025-10-222025-10-22

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_________________________________________________________
FORM 8-K
 
_________________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) October 22, 2025
 
 _________________________________________________________
CME GROUP INC.
(Exact Name of Registrant as Specified in its Charter) 
_________________________________________________________ 
Delaware 001-31553 36-4459170
(State or Other Jurisdiction
of Incorporation)
 (Commission
File No.)
 (IRS Employer
Identification No.)
 
20 South Wacker DriveChicagoIllinois 60606
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (312930-1000
N/A
(Former Name or Former Address, if Changed Since Last Report) 
______________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbolName of each exchange on which registered
Class A Common StockCMENasdaq
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  



If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 2.02.Results of Operations and Financial Condition.
The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Attached and incorporated herein by reference as Exhibit 99.1 is a copy of a press release of CME Group Inc. dated October 22, 2025, reporting CME Group Inc.’s financial results for the quarter ended September 30, 2025.
To supplement CME Group’s financial statements on a GAAP basis, the attached press release includes financial measures that are not in accordance with GAAP, consisting of non-GAAP revenues, expenses, operating income, net income and earnings per share. Management believes that the presentation of non-GAAP revenues, expenses, operating income, net income and earnings per share provide important supplemental information to management and investors about financial and business trends relating to CME Group Inc.’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provide a better measure of comparability with the Company’s prior financial reports. Management acknowledges that non-GAAP adjustments may include recurring items. These non-GAAP measures should be considered as a supplement to, and not as a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. Pursuant to the requirements of Regulation G, CME Group Inc. has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in the press release.
 
Item 9.01Financial Statements and Exhibits.
Exhibit
Number
  Description
99.1   
Press Release, dated October 22, 2025.
104 The cover page from CME Group Inc.'s Current Report on Form 8-K, formatted in Inline XBRL.




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 CME Group Inc.
 Registrant
Date: October 22, 2025 By: /s/ Lynne Fitzpatrick
 Name:

Title:
 Lynne Fitzpatrick

Senior Managing Director, President and Chief Financial Officer

Principal Financial Offer and
Duly Authorized Officer
  




























FAQ

What did CME (CME) announce in this 8-K?

CME furnished a press release (Exhibit 99.1) reporting financial results for the quarter ended September 30, 2025, under Item 2.02.

Which period do the results cover for CME (CME)?

The press release covers the quarter ended September 30, 2025.

Are non-GAAP measures included for CME (CME)?

Yes. The press release includes non-GAAP revenues, expenses, operating income, net income, and EPS with GAAP reconciliations pursuant to Regulation G.

Is the information considered filed or furnished?

The Item 2.02 information, including Exhibit 99.1, is furnished and not deemed filed under Section 18 of the Exchange Act.

What exhibit accompanies the CME (CME) 8-K?

Exhibit 99.1 is the press release dated October 22, 2025; Exhibit 104 is the cover page formatted in Inline XBRL.

On which exchange is CME’s Class A Common Stock listed?

CME’s Class A Common Stock trades on Nasdaq under the symbol CME.
CME Group

NASDAQ:CME

CME Rankings

CME Latest News

CME Latest SEC Filings

CME Stock Data

96.80B
358.68M
0.44%
91.65%
1.25%
Financial Data & Stock Exchanges
Security & Commodity Brokers, Dealers, Exchanges & Services
Link
United States
CHICAGO